Sotera Health (NASDAQ:SHC - Get Free Report) is projected to release its Q1 2025 earnings data before the market opens on Thursday, May 1st. Analysts expect Sotera Health to post earnings of $0.12 per share and revenue of $245.56 million for the quarter.
Sotera Health Stock Down 1.3 %
Shares of SHC traded down $0.15 during mid-day trading on Friday, hitting $11.15. 960,744 shares of the company's stock were exchanged, compared to its average volume of 1,206,052. The company has a quick ratio of 2.61, a current ratio of 2.88 and a debt-to-equity ratio of 4.91. Sotera Health has a twelve month low of $9.53 and a twelve month high of $17.08. The firm has a fifty day moving average of $11.56 and a two-hundred day moving average of $13.17. The stock has a market cap of $3.16 billion, a price-to-earnings ratio of 44.60 and a beta of 1.88.
Analyst Ratings Changes
Several equities research analysts recently weighed in on SHC shares. Piper Sandler reduced their target price on Sotera Health from $15.00 to $13.00 and set a "neutral" rating for the company in a report on Wednesday. Barclays reduced their target price on shares of Sotera Health from $16.00 to $12.00 and set an "overweight" rating for the company in a research note on Thursday, April 10th. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $15.20.
Check Out Our Latest Research Report on SHC
About Sotera Health
(
Get Free Report)
Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.
Further Reading
Before you consider Sotera Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sotera Health wasn't on the list.
While Sotera Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
